Inventor · disambiguated record
Alan D'Andrea
Also filed as: D ANDREA ALAN · D'ANDREA ALAN D
23 granted patents·9 pending applications·248 citations·filing 1991–2022
95Inventor score
Files withDANA FARBER CANCER INST INC22D ANDREA ALAN D5GENETICS INST2D ANDREA ALAN1DANA-FARBER CANCER INSTITUTE INC1
Top patents by PatentIndex Score
32 records- 0193US10653676B2Small molecule inhibitors of USP1 deubiquitinating enzyme activityDANA FARBER CANCER INST INC·Filed 2016·Granted May 19, 2020·9 cites·12 claims
- 0293US8541192B2Methods to identify USP1 deubiquitinating enzyme complex inhibitorsD ANDREA ALAN D·Filed 2010·Granted Sep 24, 2013·13 cites·4 claims
- 0391US7858331B2Compositions and methods for the treatment of cancerDANA FARBER CANCER INST INC·Filed 2006·Granted Dec 28, 2010·25 cites·7 claims
- 0491US7754463B2Inhibitors of USP1 Deubiquitinating Enzyme ComplexDANA FARBER CANCER INST INC·Filed 2007·Granted Jul 13, 2010·17 cites·4 claims
- 0590US7459287B2Method for determination and quantification of radiation or genotoxin exposureDANA FARBER CANCER INST INC·Filed 2005·Granted Dec 2, 2008·10 cites·5 claims
- 0689US5278065ARecombinant DNA endoding an erythropoietin receptorGENETICS INST·Filed 1991·Granted Jan 11, 1994·81 cites·18 claims
- 0788US9518032B2Small molecule inhibitors of USP1 deubiquitinating enzyme activityD'ANDREA ALAN D·Filed 2011·Granted Dec 13, 2016·14 cites·3 claims
- 0885US11413288B2Methods of treating cancersDANA FARBER CANCER INST INC·Filed 2018·Granted Aug 16, 2022·3 cites·9 claims
- 0984US10450281B1Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2017·Granted Oct 22, 2019·3 cites·20 claims
- 1084US5378808ARecombinant erythropoietin receptor proteinGENETICS INST·Filed 1993·Granted Jan 3, 1995·58 cites·3 claims
- 1178US9725425B1Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2015·Granted Aug 8, 2017·2 cites·16 claims
- 1277US11224608B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2018·Granted Jan 18, 2022·1 cites·45 claims
- 1373US12263166B2Methods of treating cancers having a BRCA1 and/or BRCA2 mutation(s)DANA FARBER CANCER INST INC·Filed 2022·Granted Apr 1, 2025·0 cites·12 claims
- 1469US10526402B2Anti-TGF-beta antibody for the treatment of fanconi anemiaDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 7, 2020·2 cites·15 claims
- 1569US7910325B2Method for determination and quantification of radiation or genotoxin exposureDANA FARBER CANCER INST INC·Filed 2008·Granted Mar 22, 2011·0 cites·24 claims
- 1667US8597900B2Compositions and methods for the treatment of cancerD ANDREA ALAN D·Filed 2010·Granted Dec 3, 2013·1 cites·7 claims
- 1766US2020140868A1Compositions and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1866US2009081237A1Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agentsDANA FARBER CANCER INST INC·Filed 2008·Application pending·0 cites
- 1960US10738310B2Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitorDANA-FARBER CANCER INSTITUTE INC·Filed 2015·Granted Aug 11, 2020·0 cites·13 claims
- 2059US9354224B2Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereofDANA FARBER CANCER INST INC·Filed 2014·Granted May 31, 2016·0 cites·2 claims
- 2157US2009062196A1Compositions and methods of treating cancerD ANDREA ALAN·Filed 2007·Application pending·0 cites
- 2256US8541198B2Method for determination and quantification of radiation or genotoxin exposureD ANDREA ALAN D·Filed 2011·Granted Sep 24, 2013·0 cites·4 claims
- 2355USRE50319ECompounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2018·Granted Mar 4, 2025·0 cites·70 claims
- 2453US2013157294A1Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment ThereofDANA FARBER CANCER INST INC·Filed 2012·Application pending·0 cites
- 2552US11421218B2Methods for enhancing the efficiency of gene editingDANA FARBER CANCER INST INC·Filed 2017·Granted Aug 23, 2022·0 cites·7 claims
- 2650US11707481B2Compositions and methods of treating Fanconi AnemiaDANA FARBER CANCER INST INC·Filed 2016·Granted Jul 25, 2023·0 cites·10 claims
- 2749US2013280258A1Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agentsD ANDREA ALAN D·Filed 2012·Application pending·0 cites
- 2848US2011257036A1Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment ThereofDANA FARBER CANCER INST INC·Filed 2010·Application pending·0 cites
- 2946US6287858B1DeUBiquitinating enzymes that regulate cell growthDANA FARBER CANCER INST INC·Filed 1998·Granted Sep 11, 2001·9 cites·31 claims
- 3043US2003188326A1Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereofDANA FARBER CANCER INST INC·Filed 2002·Application pending·0 cites
- 3137US2019055563A1Polymerase q as a target in hr-deficient cancersDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
- 3231US2003093819A1Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alan D'Andrea files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →